End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51,700 KRW | -1.34% | -8.66% | -28.19% |
05-03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
03-28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Sales 2024 * | 242B 175M 239M | Sales 2025 * | 325B 235M 320M | Capitalization | 3,972B 2.88B 3.92B |
---|---|---|---|---|---|
Net income 2024 * | -37B -26.79M -36.48M | Net income 2025 * | -17B -12.31M -16.76M | EV / Sales 2024 * | 11.3 x |
Net cash position 2024 * | 1,242B 899M 1.22B | Net cash position 2025 * | 663B 480M 654M | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-106
x | P/E ratio 2025 * |
-225
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.48% |
1 day | -1.34% | ||
1 week | -8.66% | ||
1 month | -11.77% | ||
3 months | -15.80% | ||
6 months | -23.75% | ||
Current year | -28.19% |
Managers | Title | Age | Since |
---|---|---|---|
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Yong-Sung Choi
DFI | Director of Finance/CFO | 51 | - |
Sally Choe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Choi
BRD | Director/Board Member | 60 | - |
Chang-Jin Moon
BRD | Director/Board Member | 71 | - |
Jae-Yong An
CEO | Chief Executive Officer | 56 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -5.07% | ||
0.04% | 15 M€ | +13.60% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 51,700 | -1.34% | 242,151 |
24-05-30 | 52,400 | -4.38% | 184,975 |
24-05-29 | 54,800 | -2.49% | 132,430 |
24-05-28 | 56,200 | -0.88% | 78,400 |
24-05-27 | 56,700 | +0.18% | 60,225 |
End-of-day quote Korea S.E., May 30, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.19% | 2.87B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-17.66% | 7.32B |
- Stock Market
- Equities
- A302440 Stock